CMOPF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Cosmo Pharmaceuticals (CMOPF) Ownership - Who owns Cosmo Pharmaceuticals?

Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Sir John Rogersonâ€™s Quay

Phone

+353 18170370

Employees

295

Web

https://www.cosmopharma.com

Details

Group

Domestic Stock Funds

Fundamentals

CMOPF

Capitalization

828M

P/E Ratio

68.49

Risk (Beta)

0.29

Dividend Yield

0.02

Total Cash

222M

Total Cash/Share

13.81

Total Debt

176M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

7.08%

Revenue

104M

ROE

N/A

Book Value

431M

P/B Ratio

1.70

Cash Flow

N/A

Earnings

0.67

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

4.56M

Current Ratio

1.42

Current Revenue Per Employee

N/A

Dividends Per Share - Security

0.95

EBITDA

42.1M

Float

N/A

Float - Current

N/A

Gross Income Margin

76.25

Revenue To Assets

1.44

Shares Held By Institutions

95.9M

Shares Outstanding - Current

16.1M

Total Liabilities

299M

Total Volume MTD

N/A

Value

Gain YTD

9.824

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsMajor